Discussion The present study offers novel insights into the therapeutic potential of GLP-1 agonists in the context of RV dysfunction
Even though this dose is nearly 500 times the RDA, it seems to be very common
SB: Supervision, Conceptualization, Writing review & editing
Thousands of anecdotal reports support its safety for: Subcutaneous and intramuscular injection Oral use for GI issues Short-term protocols (26 weeks) Still, because of its unregulated status, quality and dosing inconsistencies in peptide sourcing pose additional risks
Bottom line Medicare covers Ozempic (semaglutide) for type 2 diabetes, but not for weight loss
Some users prefer morning injection to support daytime activity and recovery, while others favor evening administration to align with natural growth hormone release during sleep